Invasive disease caused by Haemophilus influenzae in Sweden 1997–2009; evidence of increasing incidence and clinical burden of non-type b strains  F.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
L. Boyanova  Clinical Microbiology and Infection 
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome  J. Guinea, M. Torres-Narbona, P.
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients  M. Giannella, M. Alonso,
Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia 
Herpes zoster in non-hospitalized children
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects  K. Ekelund, P. Skinhøj, J. Madsen, H.B.
E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
The spread and clinical impact of ST14CC-PBP3 type IIb/A, a clonal group of non- typeable Haemophilus influenzae with chromosomally mediated β-lactam resistance—a.
The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.  S. Pereyre, A. Touati,
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR  T. Kallonen, J.
M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen 
Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca  N. Moustaoui,
Vector control: a cornerstone in the malaria elimination campaign
A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period  P. Harris, D.-A. Siew, M. Proud, P. Buettner,
Community-acquired pneumonia: the evolving challenge
J. Du, X. Wang, Y. Hu, Z. Li, Y. Li, S. Sun, F. Yang, Q. Jin 
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
Levofloxacin in the treatment of ventilator-associated pneumonia
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region  K.B. Laupland, D.B. Gregson, D.L. Church,
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Cases of travel-acquired dengue fever in Denmark 2001–2009
Metagenomics and probiotics
Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel  M. Weinberger, S. Yaron, V. Agmon, R. Yishai, A.
T. Norén, K. Johansson, M. Unemo  Clinical Microbiology and Infection 
Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008)  C. Esteva, L. Selva, M.F.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Detection of human coronavirus NL63, human metapneumovirus and respiratory syncytial virus in children with respiratory tract infections in south-west.
Community-acquired pneumonia: epidemiologic and clinical consideration
The role of antimalarial treatment in the elimination of malaria
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine 
Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes.
Current experience in treating invasive zygomycosis with posaconazole
Fibronectin concentrations in catheter sepsis
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae  I. Gustafsson, O. Cars  Clinical Microbiology.
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures  B. Herer, C. Fuhrman, Z. Gazevic,
Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia  U. Hohenthal, S. Hurme, H. Helenius,
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study 
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched.
Are we losing the fight against malaria one more time?
Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain  J.-Y. Wang, H.-L.
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Enhanced isolation of Legionella species from composted material
The future of diagnostic bacteriology
Presentation transcript:

Invasive disease caused by Haemophilus influenzae in Sweden 1997–2009; evidence of increasing incidence and clinical burden of non-type b strains  F. Resman, M. Ristovski, J. Ahl, A. Forsgren, J.R. Gilsdorf, A. Jasir, B. Kaijser, G. Kronvall, K. Riesbeck  Clinical Microbiology and Infection  Volume 17, Issue 11, Pages 1638-1645 (November 2011) DOI: 10.1111/j.1469-0691.2010.03417.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 The incidence of invasive Haemophilus influenzae disease increased significantly during the years 1997–2009. (a) Total incidence of invasive H. influenzae disease per 100 000 individuals and year from the primary analysis (regardless of serotype) (n = 410). The increase in incidence was statistically significant (p ≤ 0.001). (b) Results from the secondary analysis, comprising 285 defined cases are shown. The increase was statistically significant (p 0.001 and p 0.025 for non-typeable H. influenzae (NTHi) and H. influenzae type f (Hif), respectively). Isolates (n = 17) that had not been saved or previously defined by PCR are indicated as not analysed (N/A). Regardless of the hypothetical outcome of the 17 non-analysed isolates, the increase of invasive NTHi disease remained statistically significant. Clinical Microbiology and Infection 2011 17, 1638-1645DOI: (10.1111/j.1469-0691.2010.03417.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 The incidence per patient age group of invasive Haemophilus influenzae disease per 100 000 age-group-sorted individuals at risk is shown. The incidence increased significantly in the age groups 60–80 years and >80 years during the course of the study (p 0.002 and p 0.006, respectively). When the results from PCR serotyping were taken into account, the increase was mainly ascribed to non-typeable H. influenzae (NTHi), but in part also to H. influenzae type f (Hif). Clinical Microbiology and Infection 2011 17, 1638-1645DOI: (10.1111/j.1469-0691.2010.03417.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 The clinical burden from invasive Haemophilus influenzae non-type b disease is increasing. The line with filled circles shows total days of hospitalization of patients with invasive H. influenzae non-type b disease per 100 000 individuals at risk in the county of Skåne (left y-axis). The number from 2002 is high because of two cases with unusually long periods of hospitalization (>50 days). The increase in hospitalization days during the years 1997–2009 was significant (p 0.046). For comparison, the black and grey bars show the decreased average times of hospitalization/case due to pneumonia and sepsis in the city of Malmö, Skåne county 2001–2009 (right y-axis). Clinical Microbiology and Infection 2011 17, 1638-1645DOI: (10.1111/j.1469-0691.2010.03417.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions